Financial News

Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

33.41 +0.94 (+2.89%)

Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

33 34 Next >

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? ↗

June 27, 2025

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

Via The Motley Fool

Topics Intellectual Property

Massive News for Hims & Hers Stock Investors! ↗

June 27, 2025

Via The Motley Fool

Down Over 30%, What's Going on With Hims & Hers stock? ↗

June 27, 2025

Via The Motley Fool

2 Volatile Stocks Worth Your Attention and 1 to Turn Down

June 27, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

This Weight Loss Partnership Was a Short One ↗

June 26, 2025

Via The Motley Fool

Topics Economy

After Its Biggest Drop Ever...Is HIMS A Buy? ↗

June 25, 2025

Via Benzinga

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

June 26, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the company's CEO stated that it will continue to offer cheaper, compounded versions of GLP-1...

Via StockStory

Topics Artificial Intelligence

What's Going On With Hims & Hers Health Stock Today? ↗

June 26, 2025

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here's a look at what you need to know.

Via Benzinga

Behind the Scenes of Hims & Hers Health's Latest Options Trends ↗

June 26, 2025

Via Benzinga

Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity? ↗

June 26, 2025

Via The Motley Fool

4 Health Care Stocks With Whale Alerts In Today's Session ↗

June 25, 2025

Via Benzinga

Hims & Hers CEO Says 'No Way In Hell We're Gonna Cave On' Selling Compounded Obesity Drugs After Novo Nordisk Breakup ↗

June 24, 2025

Truist warned that Hims faces renewed litigation risk after Novo's exit, which could create a prolonged legal overhang on the stock.

Via Stocktwits

Topics Law Enforcement Lawsuit

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail? ↗

June 24, 2025

Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must decide if it's a buying opportunity or a warning sign for the industry.

Via Benzinga

Why Hims & Hers Stock Could Be a Multi-Bagger in the Making

June 24, 2025

Hims & Hers stock keeps giving investors more reasons to buy, and has all the right factors to turn it into a potential multi-bagger investment.

Via MarketBeat

Topics Economy

Why Did Hims and Hers Stock Crash on Monday? ↗

June 24, 2025

Via The Motley Fool

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know ↗

June 24, 2025

Via The Motley Fool

Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed' ↗

June 24, 2025

Hims & Hers Health CEO Andrew Dudum has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy.

Via Benzinga

Market Monitor News June 24 BMO (Tesla, Northern Trust UP - Hims&Hers, Super Micro Computer DOWN) ↗

June 24, 2025

Markets Brush Off Missiles and Missteps — Sentiment Stays Surprisingly Resilient

Via Chartmill

Circle Internet, AMD, Nvidia, Hims & Hers, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

June 23, 2025

On Monday, major U.S. indices ended the day in the green with the Dow Jones Industrial Average rising 0.9% to 42,581.78, and the S&P 500 gaining nearly 1% to 6,025.17.

Via Benzinga

Topics Stocks

Hims & Hers Stock Rebounds After-Hours After Novo Nordisk Split Triggers Record Plunge — Retail Traders Stay Loyal ↗

June 23, 2025

On Stocktwits, 24-hour message volume around HIMS soared 6,717% — the fifth highest among healthcare stocks. It was the top trending ticker on the platform late Monday.

Via Stocktwits

Why Hims & Hers Health Stock Is Crashing Today ↗

June 23, 2025

Via The Motley Fool

Topics Stocks

What's going on in today's session ↗

June 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Hims & Hers CEO Hits Back At Novo Nordisk After Abrupt End Of Collaboration, Alleges Wegovy-Maker Is ‘Misleading The Public’ ↗

June 23, 2025

HIMS CEO said that the pharma company’s commercial team has been increasingly pressuring the company to control clinical standards and steer patients to Wegovy regardless of whether it is clinically...

Via Stocktwits

Stocks Rise, Oil Tumbles Despite Iran's Strikes On US Bases: What's Driving Markets Monday? ↗

June 23, 2025

Wall Street resilient as Iran fires missiles at U.S. bases in Qatar and Iraq, defying expectations in energy market. U.S. equities and gold up, bonds down.

Via Benzinga

Topics Bonds

Discover the most active stocks in Monday's session. ↗

June 23, 2025

Discover the most active stocks in Monday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 23, 2025

Via Benzinga

Crude Oil Falls 1%; US Services PMI Declines In June ↗

June 23, 2025

Via Benzinga

Which stocks are experiencing notable movement on Monday? ↗

June 23, 2025

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why

June 23, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker of the weight loss drug Wegovy, announced it would terminate its agreement...

Via StockStory

Topics Economy

These stocks are gapping in today's session ↗

June 23, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Financial News

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

Headline News about Hims & Hers Health, Inc. Class A Common Stock

Popular Pages